- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↓ -0.2%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option and its peers as on 16 June, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| ITI Pharma and Healthcare Fund - Direct Plan - Growth Option | 6.86% | -0.2% | -0.55% | -0.69% | 11.67% | 3.09% | 20.5% | - | - | - |
| SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -7.04% | 0.14% | 2.46% | -0.4% | 5.23% | -6.27% | 8.6% | 14.02% | 15.37% | 14.89% |
| SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth | -4.4% | 0.46% | 3.16% | 3.43% | 6.82% | -0.62% | 11.11% | 10.73% | 12.59% | 12.73% |
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | 12.03% | -0.55% | 0.9% | 1.87% | 12.8% | 11.21% | 25.19% | 16.73% | 24.52% | 14.54% |
| SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH | 2.67% | 0.72% | 1.75% | 0.68% | 12.08% | 3.47% | 18.27% | 19.3% | 18.87% | 16.22% |
| SBI PSU Fund - DIRECT PLAN - GROWTH | 2.88% | -0.15% | 0.43% | -0.64% | 2.03% | 9.51% | 29.34% | 24.15% | 19.73% | 15.91% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | - | - | - | - | - | - | -6.9% | 35.22% | 44.46% | -9.08% |
Discrete returns (monthly)
| Month | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -1.75% | -1.48% | 2.29% | -1.03% | -2.44% | -6.81% | 6.98% | -4.59% | 7.71% | 3.1% |
Returns from spefic dates
| Description | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|
| Returns | 0.75% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 99.18% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 0.82% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 11.80% |
| Divi's Laboratories Limited | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 8.77% |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP (INE437A01024) | Healthcare Services | 6.60% |
| Max Healthcare Institute Limited | MAXHEALTH (INE027H01010) | Healthcare Services | 5.50% |
| Torrent Pharmaceuticals Limited | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 5.28% |
| Aurobindo Pharma Limited | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 4.99% |
| Lupin Limited | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 4.20% |
| Laurus Labs Limited | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 3.65% |
| Alkem Laboratories Limited | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 3.12% |
| Fortis Healthcare Limited | FORTIS (INE061F01013) | Healthcare Services | 2.91% |
| Neuland Laboratories Limited | NEULANDLAB (INE794A01010) | Pharmaceuticals & Biotechnology | 2.66% |
| Aster DM Healthcare Limited | ASTERDM (INE914M01019) | Healthcare Services | 2.32% |
| Abbott India Limited | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 2.32% |
| Glenmark Pharmaceuticals Limited | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 2.15% |
| Cohance Lifesciences Limited | COHANCE (INE03QK01018) | Pharmaceuticals & Biotechnology | 2.09% |
| Dr. Reddy's Laboratories Limited | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 1.87% |
| Mankind Pharma Limited | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 1.85% |
| Sai Life Sciences Limited | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 1.82% |
| IPCA Laboratories Limited | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 1.70% |
| Cipla Limited | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 1.67% |
| Park Medi World Limited | INE119201023 | Healthcare Services | 1.49% |
| Linde India Limited | LINDEINDIA (INE473A01011) | Chemicals & Petrochemicals | 1.39% |
| Biocon Limited | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 1.29% |
| SBI Life Insurance Company Limited | SBILIFE (INE123W01016) | Insurance | 1.25% |
| Healthcare Global Enterprises Limited | HCG (INE075I01017) | Healthcare Services | 1.24% |
| Sumitomo Chemical India Limited | SUMICHEM (INE258G01013) | Fertilizers & Agrochemicals | 1.21% |
| FDC Limited | FDC (INE258B01022) | Pharmaceuticals & Biotechnology | 1.16% |
| Onesource Specialty Pharma Limited | ONESOURCE (INE013P01021) | Pharmaceuticals & Biotechnology | 1.15% |
| Rainbow Childrens Medicare Limited | RAINBOW (INE961O01016) | Healthcare Services | 1.11% |
| Shaily Engineering Plastics Limited | SHAILY (INE151G01028) | Consumer Durables | 1.11% |
| Piramal Pharma Limited | PPLPHARMA (INE0DK501011) | Pharmaceuticals & Biotechnology | 1.10% |
| Jubilant Ingrevia Limited | JUBLINGREA (INE0BY001018) | Chemicals & Petrochemicals | 1.06% |
| GlaxoSmithKline Pharmaceuticals Limited | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 1.00% |
| Orchid Pharma Limited | ORCHPHARMA (INE191A01027) | Pharmaceuticals & Biotechnology | 0.83% |
| Shilpa Medicare Limited | SHILPAMED (INE790G01031) | Pharmaceuticals & Biotechnology | 0.82% |
| Standard Engineering Technology Ltd | SGLTL (INE0M4D01010) | Industrial Manufacturing | 0.82% |
| Caplin Point Laboratories Limited | CAPLIPOINT (INE475E01026) | Pharmaceuticals & Biotechnology | 0.74% |
| Zydus Lifesciences Limited | ZYDUSLIFE (INE010B01027) | Pharmaceuticals & Biotechnology | 0.69% |
| AstraZeneca Pharma India Limited | ASTRAZEN (INE203A01020) | Pharmaceuticals & Biotechnology | 0.69% |
| Poly Medicure Limited | POLYMED (INE205C01021) | Healthcare Equipment & Supplies | 0.68% |
| Supriya Lifescience Limited | SUPRIYA (INE07RO01027) | Pharmaceuticals & Biotechnology | 0.67% |
| Syngene International Limited | SYNGENE (INE398R01022) | Healthcare Services | 0.41% |
Debt
| Name | Rating | Weight % |
|---|
Portfolio data is as on date 31 March, 2026
NAV history
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 16 June, 2026 | 18.1765 | -0.2% |
| 15 June, 2026 | 18.2125 | -0.42% |
| 12 June, 2026 | 18.2901 | 0.6% |
| 11 June, 2026 | 18.1806 | 0.05% |
| 10 June, 2026 | 18.1711 | -0.58% |
| 9 June, 2026 | 18.2772 | 1% |
| 8 June, 2026 | 18.0963 | -0.12% |
| 5 June, 2026 | 18.1174 | 0.59% |
| 4 June, 2026 | 18.0105 | 0.35% |
| 3 June, 2026 | 17.9474 | 0.55% |
| 2 June, 2026 | 17.8498 | -0.61% |
| 1 June, 2026 | 17.9591 | -0.62% |
| 29 May, 2026 | 18.0712 | -1.13% |
| 27 May, 2026 | 18.2776 | -0.08% |
| 26 May, 2026 | 18.2925 | -0.36% |
| 25 May, 2026 | 18.3595 | 0.38% |
| 22 May, 2026 | 18.2903 | -1.07% |
| 21 May, 2026 | 18.4889 | 0.33% |
| 20 May, 2026 | 18.4279 | 0.16% |
| 19 May, 2026 | 18.3991 | 0.43% |
| 18 May, 2026 | 18.3196 | 0.1% |
| 15 May, 2026 | 18.3022 | -0.07% |
| 14 May, 2026 | 18.3158 | 1.72% |
| 13 May, 2026 | 18.0054 | -0.07% |
| 12 May, 2026 | 18.0175 | -1.58% |
| 11 May, 2026 | 18.3061 | 0.61% |
| 8 May, 2026 | 18.1953 | 0.33% |
| 7 May, 2026 | 18.1359 | 0.51% |
| 6 May, 2026 | 18.0436 | 1.87% |
| 5 May, 2026 | 17.7129 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
The latest NAV of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option is 18.1765 as on 16 June, 2026.What are YTD (year to date) returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
The YTD (year to date) returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are 6.86% as on 16 June, 2026.What are 1 year returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
The 1 year returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are 3.09% as on 16 June, 2026.What are 3 year CAGR returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
The 3 year annualized returns (CAGR) of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are 20.5% as on 16 June, 2026.